Evaluation of the prognostic potential of histopathological subtyping in high-grade serous ovarian carcinoma.

Authors: Zelisse, Hein S., Hwan, Robin A., van de Vijver, Marc J., Dijk, Frederike, Mom, Constantijne H., Hooijer, Gerrit K. J., van Gent, Mignon D. J. M., Snijders, Malou L. H.

Source: Virchows Archiv: European Journal of Pathology; Feb2025, Vol. 486 Issue 2, p381-391, 11p

Editorial: Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes.

Authors: Hollis, Robert L., van Gent, Mignon D. J. M.

Source: Frontiers in Oncology; 2024, p1-4, 4p

Subject Terms: OVARIAN epithelial cancer, RENAL cell carcinoma, GRANULOSA cell tumors, HOMOLOGOUS recombination, CANCER diagnosis

Improving response to progestin treatment of low-grade endometrial cancer

Authors: Baxter, Eva ^{1, *}, Brennan, Donal J ^{2, 3}, McAlpine, Jessica N ^{4, 5}, Mueller, Jennifer J ^{6, 7}, Amant, Frédéric ^{8, 9}, van Gent, Mignon D J M ⁹, Huntsman, David G ^{5, 10}, Coleman, Robert L ¹¹, Westin, Shannon N ¹¹, Yates, Melinda S ¹¹, Krakstad, Camilla ^{12, 13}, Quinn, Michael A ¹⁴, Janda, Monika ¹⁵, Obermair, Andreas ¹

Source: In International Journal of Gynecological Cancer November 2020 30(11):1811-1823

DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self‐samples and cervical scrapes.

Authors: Wever, Birgit M. M., van den Helder, Rianne, van Splunter, Annina P., van Gent, Mignon D. J. M., Kasius, Jenneke C., Trum, Johannes W., Verhoeve, Harold R., van Baal, Wilhelmina M., Hulbert, Alicia, Verhoef, Lisanne, Heideman, Daniëlle A. M., Lissenberg‐Witte, Birgit I., van Trommel, Nienke E., Steenbergen, Renske D. M., Bleeker, Maaike C. G.

Source: International Journal of Cancer; Jul2023, Vol. 153 Issue 2, p341-351, 11p

Subject Terms: ENDOMETRIAL cancer, DNA methylation, EARLY detection of cancer, LOGISTIC regression analysis, URINE, ENDOMETRIAL hyperplasia

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy in Patients With Advanced Ovarian Cancer (OVHIPEC-1): Final Survival Analysis of a Randomised, Controlled, Phase 3 Trial.

Authors: Aronson, S. Lot, Lopez-Yurda, Marta, Koole, Simone N., Schagen van Leeuwen, Jules H., Schreuder, Hendrik W. R., Hermans, Ralph H. M., de Hingh, Ignace H. J. T., van Gent, Mignon D. J. M., Arts, Henriêtte J. G., van Ham, Maaike A. P. C., van Dam, Peter A., Vuylsteke, Peter, Aalbers, Arend G. J., Verwaal, Victor J., Van de Vijver, Koen K., Aaronson, Neil K., Sonke, Gabe S., van Driel, Willemien J., L. V. L.

Source: Obstetrical & Gynecological Survey; Feb2024, Vol. 79 Issue 2, p96-98, 3p

Psychological impact of referral to an oncology hospital on patients with an ovarian mass.

Authors: Lof, Pien¹ p.lof@nki.nl, Engelhardt, Ellen G.², van Gent, Mignon D. J. M.³, Mom, Constantijne H.³, Rosier van Dunné, Fleur M. F.⁴, Marchien van Baal, W.⁵, Verhoeve, Harold R.⁶, Hermsen, Brenda B. J.⁶, Verbruggen, Marjolijn B.⁷, Hemelaar, Majoie⁸, van de Swaluw, Jojanneke M. G., Knipscheer, Haye C.⁹, Huirne, Judith A. F.¹⁰, Westenberg, Steven M.¹¹, van Driel, Willemien J.¹, Bleiker, Eveline M. A.², Amant, Frédéric^1,12, Lok, Christianne A. R.¹

Source: International Journal of Gynecological Cancer. Jan2023, Vol. 33 Issue 1, p74-82. 9p.

This result is not displayed to guests.
Login for full access.

The Origin of Tumor DNA in Urine of Urogenital Cancer Patients: Local Shedding and Transrenal Excretion.

Authors: Hentschel, Anouk E., van den Helder, Rianne, van Trommel, Nienke E., van Splunter, Annina P., van Boerdonk, Robert A. A., van Gent, Mignon D. J. M., Nieuwenhuijzen, Jakko A., Steenbergen, Renske D. M., Puglisi, Fabio, Gerratana, Lorenzo

Source: Cancers; Feb2021, Vol. 13 Issue 3, p535, 1p

Subject Terms: BLOOD circulation, BODY fluid examination, CANCER patients, DNA, GENITOURINARY organ tumors, METHYLATION, NEPHROSTOMY, MOLECULAR pathology, TUMOR markers, URINALYSIS

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.

Authors: Aronson, S Lot^1,2 (AUTHOR), Lopez-Yurda, Marta³ (AUTHOR), Koole, Simone N^1,2 (AUTHOR), Schagen van Leeuwen, Jules H⁴ (AUTHOR), Schreuder, Hendrik W R⁵ (AUTHOR), Hermans, Ralph H M⁶ (AUTHOR), de Hingh, Ignace H J T^7,8 (AUTHOR), van Gent, Mignon D J M^9,10 (AUTHOR), Arts, Henriëtte J G¹¹ (AUTHOR), van Ham, Maaike A P C¹² (AUTHOR), van Dam, Peter A¹³ (AUTHOR), Vuylsteke, Peter^14,15 (AUTHOR), Aalbers, Arend G J¹⁶ (AUTHOR), Verwaal, Victor J¹⁷ (AUTHOR), Van de Vijver, Koen K¹⁸ (AUTHOR), Aaronson, Neil K¹⁹ (AUTHOR), Sonke, Gabe S^1,2 (AUTHOR), van Driel, Willemien J^1,10 (AUTHOR) w.v.driel@nki.nl

Source: Lancet Oncology. Oct2023, Vol. 24 Issue 10, p1109-1118. 10p.

Subject Terms: *HYPERTHERMIC intraperitoneal chemotherapy, *CLINICAL trials, *CANCER patients, *CYTOREDUCTIVE surgery, *SURVIVAL analysis (Biometry)

Geographic Terms: NETHERLANDS, BELGIUM